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Abstract  
Anti-N-methyl-D-aspartate receptor encephalitis 
in young healthy women while rare may be the 
result of an ovarian teratoma that produces anti-
NMDA receptor antibodies. Symptoms from this 
encephalitis can be severe enough to result in 
hypoventilation, autonomic instability, and coma. 
Although treatable with tumor removal via 
oophorectomy and immunosuppression, median 
time to diagnosis is 8 weeks, which may lead to 
the onset of severe symptoms. 
The case presented highlights the severity of 
symptoms including rhabdomyolysis and 
respiratory distress in a female who had a 
previous history of functional somatic 
syndromes, which possibly resulted in a delayed 
diagnosis. This case demonstrates the 
importance of a thorough evaluation for causes 
of new onset neurological symptoms when the 
patient’s clinical status continues to deteriorate. 
This includes an evaluation for anti-N-methyl-D-
aspartate receptor encephalitis. Following 
salpingo-oophorectomy, 
IVIG/methylprednisolone, and 
rituximab/cyclophosphamide treatment, this 
patient demonstrated improvement although she 
continues to require rehabilitation therapy, 
maintenance Keppra and low-dose Prednisone. 
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encephalitis is a paraneoplastic 
syndrome resulting in Ig-G antibodies 
against the NR1 or NR2 subunits.1 
Although rare, it is the second most 
common cause of immune-mediated 
encephalitis secondary to antibodies to 
the N-methyl D-aspartate receptor and 
may be the cause of encephalitis in up 
to 4% of patients.2 The majority of 
patients initially present with a 
prodromal syndrome, which can include 
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headache, nausea/vomiting, fatigue and 
upper-respiratory tract symptoms. Less 
than two weeks later, neuropsychiatric 
symptoms develop. These can be 
variable and include behavior and 
cognition problems, memory deficits, 
seizures, movement disorders and 
autonomic symptoms. Up to 77% of 
these patients are initially seen by 
psychiatrists and misdiagnosed with 
new-onset schizophrenia or bipolar 
disorder.3 If untreated, the disease can 
lead to lethal hypoventilation, autonomic 
instability, and catatonia.4 Given 
approximately 60% of cases in women 
are caused by an ovarian teratoma, it is 
important to rule out an ovarian mass 
when anti-NMDA encephalitis is in the 
differential diagnoses.1,5  
Despite detection in 1997 and being 
formally defined in 2007, it is typically 
not considered in the initial differential 
diagnosis leading to treatment delays up 
to 8 weeks.4 We present a case in which 
the patient developed rhabdomyolysis 
and acute respiratory failure before anti-
N-methyl D-aspartate receptor 
encephalitis from a 7 cm left ovarian 
teratoma was diagnosed and removed.  
Case Report 
A 31 year old Gravida 2 Para 2 with a 
history of Ehlers-Danlos, fibromyalgia 
and chronic back pain initially presented 
to an outside hospital for a worsening 
headache, left lower extremity 
weakness, falling, and palpitations. She 
developed a headache 3 days before 
presentation. She had experienced 
episodes of weakness in her arms and 
legs resulting in three falls. Upon 
evaluation in the emergency 
department, she developed aphasia and 
had a tonic-clonic seizure. Subsequent 
evaluation including MRI revealed no 
abnormality. A transfer to our institution 
was requested and granted for further 
evaluation by Neurology. An EEG was 
performed during her spells and was 
unremarkable. She was discharged on 
hospital day 3 with the diagnosis of new 
onset generalized tonic-clonic seizures 
and a urinary tract infection with follow 
up planned in 3 months.  
Two weeks later, she re-presented to 
the outside hospital with persistent 
weakness and continued spells. After a 
two week admission at the outside 
hospital, she was transferred back to 
our institution and admitted to 
Neurology. Pseudoseizures were initially 
suspected, initiating transfer to 
Psychiatry for further evaluation. 
Overnight, she developed jerking 
episodes, tachycardia to the 170 bpm’s, 
tachypnea with respiratory rate in 40’s 
and febrile to 40.6o C. Further labs 
revealed rhabdomyolysis with a creatine 
kinase of 40,000 U/L and acute kidney 
injury with a creatinine of 2.5 mg/dL. 
She continued to deteriorate and was 
transferred to the medical intensive care 
unit due to acute respiratory 
decompensation necessitating 
intubation. Subsequently the patient was 
evaluated for autoimmune encephalitis, 
including cerebral spinal fluid analysis 
for paraneoplastic syndromes, West Nile 
Virus, HSV 1/2, and the anti-NMDA 
receptor antibody. A gynecologic 
ultrasound was also requested to 
evaluate for a teratoma. 
Transabdominal ultrasound revealed a 
6.8 x 3.9 x 5.7 cm solid mass with cystic 
components, calcifications and striations 
consistent with a mature teratoma 
(Figure 1).   
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Figure 1: Transabdominal Ultrasound imaging demonstrating striations within the 
cystic component that most likely represent hair. 
 
Upon discovery of the pelvic mass, 
Gynecology was consulted for surgical 
intervention as the patient was rapidly 
deteriorating and the primary team was 
concerned the likely teratoma was the 
source of antibodies causing the 
patient’s encephalitis. The patient was 
unable to give consent given intubated 
and sedated status; however, consent 
was obtained from her mother who 
noted the patient had completed child 
bearing as evidenced by her history of 
tubal ligation. The patient was taken to 
the operating room and a laparoscopic 
left salpingo-oophorectomy was 
performed. Figure 2 demonstrates 
laparoscopic findings. Upon removal, 
sebum and hair were present within the 
mass, making the likely diagnosis of 
teratoma. Pathology later confirmed a 
mature teratoma containing hair bearing 
skin and an immature tooth. Later, 
NMDA-receptor antibodies in the CSF 
and serum returned positive titers of 
1:128 and 1:40 respectively.  
The patient was started on IVIG therapy 
for 4 days and IV methylprednisolone for 
5 days. She did relapse 10 days later 
and was then started on rituximab, 
which was given weekly for a total of 
four doses. One week later, 
cyclophosphamide was initiated as well 
with improvement noted after one day.  
She was extubated and continued to 
regain her baseline functional status. 
She was discharged to a rehabilitation 
facility on clonazepam and 
levetiracetam for myoclonus and 
prednisone for immunosuppression. 
After five months she continues to have 
some difficulty with ambulatory 
balancing, but her myoclonus has 
resolved and her cognitive function has 
fully returned. 
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encephalitis typically presents in young, 
healthy women under 45 years with 
prodromal symptoms reflecting the 
common cold that progress to 
excitotoxic symptoms such as seizures, 
movement disorders, and autonomic 
instability.1,3 Up to 60% of the time, 
these patients will have an underlying 
ovarian teratoma that, when removed in 
combination with immunotherapy can 
result in recovery and resolution of 
symptoms4 as demonstrated in the case 
presented. Neuronal tissue in the 
teratoma is usually the source of the 
antibody production; however, other 
tissue such as squamous tissue has 
been shown to stain positive for the 
antibody.6 Currently the tissue is only 
tested for experimental purposes given 
the rarity of this condition and cost of the 
immunochemical stains. While anti-N-
methyl-D aspartate receptor encephalitis 
is uncommon, mature teratomas are in 
fact common. It is worth noting that 
mature teratomas have an incidence of 
20-25% and the vast majority of the time 
they will have an indolent course.5 
Unfortunately, early diagnosis is often 
missed in patients with underlying 
functional somatic syndromes as with 
our patient. Younger female patients 
presenting with new onset seizure-like 
activity combined with mood lability 
should be tested for anti-N-methyl-D-
aspartate receptor encephalitis if EEG is 
non-diagnostic. It still remains a 
challenge when symptoms mainly 
consist of mood disturbances, agitation, 
or other seizure like activity as this can 
result in a psychiatric consult instead of 
a medicine or neurology consult. It is 
important in these instances to also 
evaluate for an organic pathology before 
solely accepting the functional 
diagnoses to avoid a delay in treatment. 
The longer diagnosis is delayed, the 
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more likely the patient will develop more 
severe excitotoxic symptoms.4 These 
can include hypoventilation, coma, or 
status epilepticus.3  
Full recovery rates are increased with 
early tumor removal versus late or no 
removal (72% versus 36%) as well as a 
decreased rate of fatality.4,5 Immediate 
removal of the teratoma, along with 
immunotherapy is recommended. First 
line therapy is typically IV 
methylprednisolone and IVIG or 
plasmapheresis.3 If continued autonomic 
instability or neuropsychiatric symptoms 
are present, the patient should be given 
rituximab and cyclophosphamide.3 
Patients typically recover, but this is 
dependent on the timing of symptom 
presentation to treatment.   
In our patient, delayed diagnosis 
resulted in development of 
rhabdomyolysis from status epilepticus 
and acute respiratory failure due to 
prolonged hypoxemia. This case 
highlights the importance of keeping 
anti-N-methyl-D-aspartate receptor 
encephalitis in the differential when the 
patient is presenting with new onset 
seizure like activity in combination with 
neurological and mood disturbances as 
missing the diagnosis can significantly 
alter the patient’s chance of intact 
survival.   
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